The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1343
ISSUE1343
July 26, 2010
Pitavastatin (Livalo) - The Seventh Statin
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Pitavastatin (Livalo) - The Seventh Statin
July 26, 2010 (Issue: 1343)
The FDA has approved the marketing of pitavastatin (Livalo – Kowa), an HMG-CoA reductase inhibitor
(“statin”), for treatment of primary hyperlipidemia or mixed dyslipidemia. It has been available in Japan
since 2003. All of the statins now...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.